Compere; Delphine

Patent Applications and Registrations

Patent applications and USPTO patent grants for Compere; Delphine.The latest application filed is for "compounds and compositions comprising the same for treating hypertension or heart failure".

Company Profile

0.11.14

Compere; Delphine - Sceaux FR
Compere, Delphine - Paris FR
Compere, Delphine - Fresnes Cedex FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and compositions comprising the same for treating hypertension or heart failure Grant 11,345,658 - Balavoine , et al. May 31, 2	2022-05-31
Compounds And Compositions Comprising The Same For Treating Hypertension Or Heart Failure App 20220041548 - BALAVOINE; FABRICE ; et al.	2022-02-10
Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same Grant 11,192,907 - Balavoine , et al. December 7, 2	2021-12-07
Aminopeptidase A Inhibitors And Pharmaceutical Compositions Comprising The Same App 20210309678 - BALAVOINE; FABRICE ; et al.	2021-10-07
Novel Aminophosphinic Derivatives As Aminopeptidase A Inhibitors App 20210309677 - BALAVOINE; FABRICE ; et al.	2021-10-07
Piperidine derivatives as human papilloma virus inhibitors Grant 9,974,779 - Blumenfeld , et al. May 22, 2	2018-05-22
Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus Grant 9,908,858 - Blumenfeld , et al. March 6, 2	2018-03-06
Piperidine Derivatives As Human Papilloma Virus Inhibitors App 20180021318 - BLUMENFELD; Marta ; et al.	2018-01-25
Pharmaceutical composition of a papillomavirus inhibitor Grant 9,670,159 - Blumenfeld , et al. June 6, 2	2017-06-06
Piperidine Derivatives As Human Papilloma Virus Inhibitors App 20170079968 - BLUMENFELD; Marta ; et al.	2017-03-23
Piperidine derivatives as human papilloma virus inhibitors Grant 9,452,991 - Blumenfeld , et al. September 27, 2	2016-09-27
Method For The Synthesis Of A Hydrazine That Can Be Used In The Treatment Of The Papilloma Virus App 20150353517 - BLUMENFELD; Marta ; et al.	2015-12-10
Pharmaceutical Composition Of A Papillomavirus Inhibitor App 20150152051 - Blumenfeld; Marta ; et al.	2015-06-04
Human papilloma virus inhibitors and pharmaceutical compositions containing same Grant 8,440,833 - Blumenfeld , et al. May 14, 2	2013-05-14
Piperidine Derivatives As Human Papilloma Virus Inhibitors App 20120220633 - Blumenfeld; Marta ; et al.	2012-08-30
Benzoic acid derivatives as human papilloma virus inhibitors Grant 8,207,373 - Blumenfeld , et al. June 26, 2	2012-06-26
Human Papilloma Virus Inhibitors And Pharmaceutical Compositions Containing Same App 20100286162 - Blumenfeld; Marta ; et al.	2010-11-11
Piperidine Derivatives As Human Papilloma Virus Inhibitors App 20090209586 - Blumenfeld; Marta ; et al.	2009-08-20
Fluorothiophene derivatives, process for preparing them and pharmaceutical compositions containing them App 20050014817 - Compere, Delphine ; et al.	2005-01-20
Thiophene amino acid derivatives, process for preparing them and pharmaceutical compositions containing them App 20050014816 - Compere, Delphine ; et al.	2005-01-20
Matrix metalloproteinase inhibitors and methods for identification of lead compounds App 20040171543 - Dublanchet, Anne-Claude ; et al.	2004-09-02
Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them App 20040072871 - Dublanchet, Anne-Claude ; et al.	2004-04-15
Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them Grant 6,232,319 - Marazano , et al. May 15, 2	2001-05-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.